Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis.
作者:
主题词
动物(Animals);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);疾病模型, 动物(Disease Models, Animal);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);女(雌)性(Female);血液肿瘤(Hematologic Neoplasms);人类(Humans);Janus激酶2(Janus Kinase 2);小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);突变, 误义(Mutation, Missense);磷酰化(Phosphorylation);血小板计数(Platelet Count);原发性骨髓纤维化(Primary Myelofibrosis);蛋白激酶抑制剂(Protein Kinase Inhibitors);受体, 血小板生成素(Receptors, Thrombopoietin);STAT3转录因子(STAT3 Transcription Factor);STAT5转录因子(STAT5 Transcription Factor);信号传导(Signal Transduction);血小板增多(Thrombocytosis)
DOI
10.1182/blood-2009-04-218842
PMID
20154217
发布时间
2021-10-20
- 浏览27

Blood
2919-27页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文